Vimarsana
Biggest News Aggregation in the World

Scientific Platform Session News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scientific Platform Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scientific Platform Session Today - Breaking & Trending Today

Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15 - Vimarsana News

Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15

Published: April 3, 2024

PACIFIC Study Phase 1b/2a clinical data to be featured in a podium presentation at an Emerging Science Session at the AAN Annual Meeting Data will be featured in an encore presentation at the...

Source: marketscreener.com
Related Topics:
United StatesRandall KayeEncephalopathies DeesLongboard Pharmaceuticals IncExchange CommissionLongboard PharmaceuticalsChief Medical OfficerEpileptic EncephalopathiesAdult PatientsEmerging Science SessionScientific Platform SessionPresentation NumberSeventeenth Eilat ConferenceNew Antiepileptic DrugsPrivate Securities Litigation Reform Act
AISA Pharma Announces Upcoming Profervia® Data Presentations at AAN and EULAR - Vimarsana News

AISA Pharma Announces Upcoming Profervia® Data Presentations at AAN and EULAR

Published: April 3, 2023

/PRNewswire/ -- Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company, today announced it will present data on its clinical drug candidate,...

Source: prnewswire.com
Related Topics:
United StatesAndrew SternlichtAisa Pharma IncAmerican Academy Of NeurologyPrnewswire Aisa Pharma IncEuropean Alliance Of AssociationsPositive PhaseSystemic SclerosisAmerican AcademyScientific Platform SessionNoveln Type Specific Calcium Channel AntagonistHas Potent ActivityWhich May Have ImplicationsCertain Neuropathic PainEuropean AllianceNovel Daily Oral Calcium Channel BlockerN Channel SelectivityPoster DiscussionAisa Pharma